| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |